Search Results - "Bass, Amr K. A."
-
1
Application of quality-by-design for adopting an environmentally green fluorogenic determination of benoxinate hydrochloride in eye drops and artificial aqueous humour
Published in Scientific reports (26-05-2023)“…Herein, a sensitive and selective spectrofluorimetric method has been developed for the determination of the ocular local anesthetic benoxinate hydrochloride…”
Get full text
Journal Article -
2
New Pyrimidine-5-Carbonitriles as COX-2 Inhibitors: Design, Synthesis, Anticancer Screening, Molecular Docking, and In Silico ADME Profile Studies
Published in Molecules (Basel, Switzerland) (01-11-2022)“…Two series of cyanopyrimidine hybrids were synthesized bearing either benzo[d]imidazole, benzo[d]oxazole, benzo[d]thiazole, and benzo[b]thiophene derivatives…”
Get full text
Journal Article -
3
Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors
Published in European journal of medicinal chemistry (01-01-2021)“…Despite the encouraging clinical progress of chemotherapeutic agents in cancer treatment, innovation and development of new effective anticancer candidates…”
Get full text
Journal Article -
4
Design of Multi-Target drugs of HDACs and other Anti-Alzheimer related Targets: Current strategies and future prospects in Alzheimer’s diseases therapy
Published in Bioorganic chemistry (01-10-2024)“…[Display omitted] •The HDACs ability to synergistically boost the performance of other anti-AD drugs, as well as the ease with which HDACs inhibitor cap group,…”
Get full text
Journal Article -
5
Design, synthesis and anticonvulsant activity of new imidazolidindione and imidazole derivatives
Published in Bioorganic chemistry (01-08-2020)“…[Display omitted] •New imidazolidindione and tetrasubstituted imidazole derivatives were synthesized and structurally approved.•The anticonvulsant activity of…”
Get full text
Journal Article -
6
Utilization of cyanopyridine in design and synthesis of first-in-class anticancer dual acting PIM-1 kinase/HDAC inhibitors
Published in Bioorganic chemistry (01-02-2022)“…[Display omitted] •Twenty-one cyanopyridine derivatives were designed as PIM-1/HDAC inhibitors.•3b, 3c, 4d, 4e, 4b and 4g showed the most active activity…”
Get full text
Journal Article